160 related articles for article (PubMed ID: 12646285)
1. Mu-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase.
Iglesias M; Segura MF; Comella JX; Olmos G
Neuropharmacology; 2003 Mar; 44(4):482-92. PubMed ID: 12646285
[TBL] [Abstract][Full Text] [Related]
2. mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control.
Polakiewicz RD; Schieferl SM; Gingras AC; Sonenberg N; Comb MJ
J Biol Chem; 1998 Sep; 273(36):23534-41. PubMed ID: 9722592
[TBL] [Abstract][Full Text] [Related]
3. Role of CDK5 in neuroprotection from serum deprivation by mu-opioid receptor agonist.
Wang Y; Xie WY; He Y; Wang M; Yang YR; Zhang Y; Yin DM; Jordan-Sciutto KL; Han JS; Wang Y
Exp Neurol; 2006 Dec; 202(2):313-23. PubMed ID: 16879821
[TBL] [Abstract][Full Text] [Related]
4. Phosphoinositide 3-kinase cascade facilitates mu-opioid desensitization in sensory neurons by altering G-protein-effector interactions.
Tan M; Groszer M; Tan AM; Pandya A; Liu X; Xie CW
J Neurosci; 2003 Nov; 23(32):10292-301. PubMed ID: 14614088
[TBL] [Abstract][Full Text] [Related]
5. delta- and mu-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
Connor M; Henderson G
Br J Pharmacol; 1996 Jan; 117(2):333-40. PubMed ID: 8789387
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to mu-opioid agonists in human neuroblastoma SH-SY5Y cells as determined by changes in guanosine-5'-O-(3-[35S]-thio)triphosphate binding.
Elliott J; Guo L; Traynor JR
Br J Pharmacol; 1997 Aug; 121(7):1422-8. PubMed ID: 9257923
[TBL] [Abstract][Full Text] [Related]
8. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
Kramer HK; Simon EJ
J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
[TBL] [Abstract][Full Text] [Related]
9. G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus.
Li AH; Wang HL
J Neurochem; 2001 Apr; 77(2):435-44. PubMed ID: 11299306
[TBL] [Abstract][Full Text] [Related]
10. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists.
Kramer HK; Simon EJ
J Neurochem; 1999 Feb; 72(2):585-93. PubMed ID: 9930730
[TBL] [Abstract][Full Text] [Related]
11. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521
[TBL] [Abstract][Full Text] [Related]
12. Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation.
Chakrabarti S; Law PY; Loh HH
J Neurochem; 1998 Jul; 71(1):231-9. PubMed ID: 9648870
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
Chandrasekher G; Sailaja D
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
[TBL] [Abstract][Full Text] [Related]
14. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
Traynor JR; Nahorski SR
Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
[TBL] [Abstract][Full Text] [Related]
15. Ultraviolet irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo.
Wan YS; Wang ZQ; Shao Y; Voorhees JJ; Fisher GJ
Int J Oncol; 2001 Mar; 18(3):461-6. PubMed ID: 11179472
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.
Molina-Holgado E; Vela JM; Arévalo-Martín A; Almazán G; Molina-Holgado F; Borrell J; Guaza C
J Neurosci; 2002 Nov; 22(22):9742-53. PubMed ID: 12427829
[TBL] [Abstract][Full Text] [Related]
17. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
18. Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival.
Zheng WH; Quirion R
J Neurochem; 2004 May; 89(4):844-52. PubMed ID: 15140184
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 protects rat PC12 cells from serum deprivation or chemotherapeutic agents through the phosphatidylinositol 3-kinase and STAT3 pathways.
Kunioku H; Inoue K; Tomida M
Neurosci Lett; 2001 Aug; 309(1):13-6. PubMed ID: 11489535
[TBL] [Abstract][Full Text] [Related]
20. Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons.
Owada K; Sanjo N; Kobayashi T; Mizusawa H; Muramatsu H; Muramatsu T; Michikawa M
J Neurochem; 1999 Nov; 73(5):2084-92. PubMed ID: 10537068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
